Thilo Hackert

Author PubWeight™ 56.30‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Small (Sendai negative) branch-duct IPMNs: not harmless. Ann Surg 2012 7.26
2 Toward the blood-borne miRNome of human diseases. Nat Methods 2011 2.14
3 Pancreatic cancer surgery in the new millennium: better prediction of outcome. Ann Surg 2011 2.02
4 CA19-9 in potentially resectable pancreatic cancer: perspective to adjust surgical and perioperative therapy. Ann Surg Oncol 2012 1.76
5 Multivisceral resection for pancreatic malignancies: risk-analysis and long-term outcome. Ann Surg 2009 1.54
6 Anaplastic pancreatic cancer: Presentation, surgical management, and outcome. Surgery 2010 1.49
7 Stimulation of Central α2 Receptors Attenuates Experimental Necrotizing Pancreatitis. Pancreas 2016 1.38
8 Advanced-stage pancreatic cancer: therapy options. Nat Rev Clin Oncol 2013 1.34
9 Re-resection for isolated local recurrence of pancreatic cancer is feasible, safe, and associated with encouraging survival. Ann Surg Oncol 2012 1.21
10 Pathology of the large intestine in patients with vascular type Ehlers-Danlos syndrome. Virchows Arch 2007 1.12
11 Bacterial translocation and infected pancreatic necrosis in acute necrotizing pancreatitis derives from small bowel rather than from colon. Am J Surg 2010 1.08
12 Pancreatic adenocarcinoma: number of positive nodes allows to distinguish several N categories. Ann Surg 2015 1.02
13 Decrease in clinically relevant pancreatic fistula by coverage of the pancreatic remnant after distal pancreatectomy. Surgery 2012 0.99
14 Radiologic versus endoscopic evaluation of the conduit after esophageal resection: a prospective, blinded, intraindividually controlled diagnostic study. Surg Endosc 2014 0.99
15 Resection after neoadjuvant therapy for locally advanced, "unresectable" pancreatic cancer. Surgery 2012 0.96
16 Acinar cell carcinoma of the pancreas: is resection justified even in limited metastatic disease? Am J Surg 2011 0.95
17 Total pancreatectomy for primary pancreatic neoplasms: renaissance of an unpopular operation. Ann Surg 2015 0.92
18 Survival data justifies resection for pancreatic metastases. Ann Surg Oncol 2009 0.91
19 Pancreatic main-duct involvement in branch-duct IPMNs: an underestimated risk. Ann Surg 2014 0.91
20 Prophylactic antibiotic treatment is superior to therapy on-demand in experimental necrotising pancreatitis. Crit Care 2008 0.90
21 Cachexia but not obesity worsens the postoperative outcome after pancreatoduodenectomy in pancreatic cancer. Surgery 2012 0.90
22 Modern phase-specific management of acute pancreatitis. Dig Dis 2003 0.86
23 LigaSure for pancreatic sealing during distal pancreatectomy. World J Surg 2010 0.86
24 A novel animal model of severe pancreatitis in mice and its differences to the rat. Surgery 2008 0.85
25 Interferon-alpha in combination with chemotherapy has potent antiangiogenic properties in an orthotopic mouse model for pancreatic adenocarcinoma. J Immunother 2008 0.85
26 No Need for Routine Drainage After Pancreatic Head Resection: The Dual-Center, Randomized, Controlled PANDRA Trial (ISRCTN04937707). Ann Surg 2016 0.85
27 Acute alcohol-induced pancreatic injury is similar with intravenous and intragastric routes of alcohol administration. Pancreas 2014 0.84
28 Protective effects and anti-inflammatory pathways of exogenous calcitonin gene-related peptide in severe necrotizing pancreatitis. Pancreatology 2009 0.83
29 Reactive hypertrophy of an accessory spleen mimicking tumour recurrence of metastatic renal cell carcinoma. Asian J Surg 2011 0.83
30 Experimental in vivo and in vitro treatment with a new histone deacetylase inhibitor belinostat inhibits the growth of pancreatic cancer. BMC Cancer 2012 0.82
31 Growth inhibition of pancreatic cancer by experimental treatment with 4-phenylbutyrate is associated with increased expression of Connexin 43. Oncol Res 2012 0.82
32 Pilot study evaluating broccoli sprouts in advanced pancreatic cancer (POUDER trial) - study protocol for a randomized controlled trial. Trials 2014 0.82
33 Effects of gadolinium chloride and glycine on hepatic and pancreatic tissue damage in alcoholic pancreatitis. Pancreas 2010 0.81
34 Interaction of complement and leukocytes in severe acute pancreatitis: potential for therapeutic intervention. Am J Physiol Gastrointest Liver Physiol 2006 0.81
35 Inosine reduces microcirculatory disturbance and inflammatory organ damage in experimental acute pancreatitis in rats. Am J Surg 2006 0.80
36 Clinicopathologic characteristics of patients with resected multifocal intraductal papillary mucinous neoplasm of the pancreas. Surgery 2012 0.80
37 Pharmacological cholinergic stimulation as a therapeutic tool in experimental necrotizing pancreatitis. Pancreas 2014 0.80
38 Buffer-dependent regulation of aquaporin-1 expression and function in human peritoneal mesothelial cells. Pediatr Nephrol 2012 0.79
39 Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 Gy) and intraoperative radiation therapy (15 Gy) in patients with primarily resectable pancreatic cancer - NEOPANC. BMC Cancer 2012 0.79
40 Pancreatic intraductal papillary mucinous neoplasm--where is the challenge? Dig Dis 2014 0.79
41 Establishment and Characterization of a Novel Cell Line, ASAN-PaCa, Derived From Human Adenocarcinoma Arising in Intraductal Papillary Mucinous Neoplasm of the Pancreas. Pancreas 2016 0.79
42 Expression and function of matrix Gla protein in human peritoneal mesothelial cells. Nephrol Dial Transplant 2010 0.78
43 Capsaicin reduces tissue damage in experimental acute pancreatitis. Pancreas 2009 0.78
44 Enterokinase induces severe necrosis and rapid mortality in cerulein pancreatitis: characterization of a novel noninvasive rat model of necro-hemorrhagic pancreatitis. Surgery 2007 0.78
45 Alcohol pretreatment increases hepatic and pulmonary injury in experimental pancreatitis. Pancreatology 2009 0.78
46 Multidrug strategies are effective in the treatment of severe experimental pancreatitis. Surgery 2011 0.78
47 Palliative resection of the primary tumor in 442 metastasized neuroendocrine tumors of the pancreas: a population-based, propensity score-matched survival analysis. Langenbecks Arch Surg 2015 0.77
48 Fundus rotation gastroplasty vs. Kirschner-Akiyama gastric tube in esophageal resection: comparison of perioperative and long-term results. World J Surg 2008 0.77
49 Teres Ligament Patch Reduces Relevant Morbidity After Distal Pancreatectomy (the DISCOVER Randomized Controlled Trial). Ann Surg 2016 0.77
50 Differential diagnosis of non-epithelial tumors of the pancreas: malignant non-epithelial pancreatic tumor with focal pigmentation. Virchows Arch 2004 0.77
51 Correlation of Histological Vessel Characteristics and Diffusion-Weighted Imaging Intravoxel Incoherent Motion-Derived Parameters in Pancreatic Ductal Adenocarcinomas and Pancreatic Neuroendocrine Tumors. Invest Radiol 2015 0.76
52 Pancreatic Cancer Surgery: The New R-status Counts. Ann Surg 2016 0.76
53 Nutritional Risk in Major Abdominal Surgery: Protocol of a Prospective Observational Trial to Evaluate the Prognostic Value of Different Nutritional Scores in Pancreatic Surgery. JMIR Res Protoc 2015 0.75
54 Expanding the indications of pancreas transplantation alone. Pancreas 2014 0.75
55 Reply to Letter: "Concerns About Acute Cholecystitis: Early Versus Delayed Cholecystectomy--A Multicenter Randomized Trial". Ann Surg 2015 0.75
56 Multiple von Meyenburg complexes mimicking diffuse liver metastases from esophageal squamous cell carcinoma. World J Gastroenterol 2006 0.75
57 Renal tumors and second primary pancreatic tumors: a relationship with clinical impact? Patient Saf Surg 2012 0.75
58 Expect the unexpected. Int J Surg Pathol 2010 0.75
59 Extended Pancreatectomy: Does It Have a Role in the Contemporary Management of Pancreatic Adenocarcinoma? Dig Surg 2017 0.75
60 Mesocaval stenting for therapy of portal hypertension after orthotopic liver transplantation. Transpl Int 2006 0.75
61 Clinical impact of perioperative myocardial infarction after pancreatic surgery. J Gastrointest Surg 2014 0.75
62 Clinical Impact of Structured Follow-up After Pancreatic Surgery. Pancreas 2016 0.75
63 Preoperative Serum Thymidine Kinase Activity as Novel Monitoring, Prognostic, and Predictive Biomarker in Pancreatic Cancer. Pancreas 2017 0.75
64 Superselective embolization for the management of postpancreatectomy hemorrhage: a single-center experience in 25 patients. J Vasc Interv Radiol 2012 0.75
65 Reply to Comment on "Teres Ligament Patch Reduces Relevant Morbidity After Distal Pancreatectomy (the DISCOVER Randomized Controlled Trial)". Ann Surg 2017 0.75